In this study, patients with EGFR-mutated NSCLC were assessed for EGFR-sensitizing and EGFR exon 20 p.T790M resistance mutations using longitudinal samples of K2EDTA whole blood (standard of care) and blood collection tubes with a novel stabilization system for comparison (Roche). This evidence concerns the gene EGFR and non-small cell lung carcinoma.